This inventor holds 1 USPTO granted patent. Top assignee: Kookmin University Industry Academy Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Harim Yang and SARS-CoV-2 Antibody Innovation.
Introduction
Harim Yang is an inventor associated with Gyeonggi-do, South Korea. His patent work concerns antibody technology targeting the SARS-CoV-2 spike protein.
Latest Patents
Yang is listed on one patent: “ANTIBODY BINDING SPECIFICALLY TO SARS-COV-2 S PROTEIN OR ANTIGEN-BINDING FRAGMENT THEREOF, BISPECIFIC ANTIBODY, AND USES THEREOF.” The invention describes antibodies that specifically bind to the SARS-CoV-2 spike protein, including antigen-binding fragments and bispecific antibodies, and their potential uses. 1 patent is attributed to him in the provided information.
Career Highlights
Yang is associated with Kookmin University Industry Academy Cooperation Foundation. The available information identifies his patent contribution but does not provide further details about his role or career history.
Collaborations
The patent’s listed collaborators include Sukmook Lee and Ji Woong Kim.
Conclusion
Harim Yang’s documented invention focuses on antibody approaches to SARS-CoV-2, developed in association with Kookmin University Industry Academy Cooperation Foundation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile